In summary, this study identifies a novel signaling pathway that accounts for EGF-induced breast cancer cell migration, including activation of Rac1, generation of ROS, subsequent activation of PI3K/Akt and PAK1. The gene discussed is EGF; the disease is breast carcinoma.